(HealthDay)— The U.S. Food and Drug Administration on Tuesday gave the nod to Emgality, an injected medication that's the first to cut the frequency of cluster headaches.
* This article was originally published here
This Blog Is Powered By Life Technology™. Visit Life Technology™ At www.lifetechnology.com Subscribe To This Blog Via Feedburner / Atom 1.0 / RSS 2.0.